Home | News | investing_ca investing_ca Aelis Farma Announces the Final Analysis of the Landmark Phase 2B Clinical Trial in Cannabis Use Disorder (CUD) with the CB1-SSi AEF0117 By April 2, 2025 investing_ca Read full story from investing_ca